REQUEST A DEMO
Total
USD $0.00
Search more companies

Pt Bhakti Persada Saudara Pharma (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Pt Bhakti Persada Saudara Pharma Profile Updated: November 14, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Pt Bhakti Persada Saudara Pharma is an enterprise based in Indonesia. Its main office is in Surabaya. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on September 18, 2026. The latest financial highlights indicate a net sales revenue increase of 9.35% in 2025. A growth of 12.66% was recorded in its total assets.

Headquarters
Jl. Pucang Sewu No. 17
Surabaya; East Java; Postal Code: 60284

Contact Details: Purchase the Pt Bhakti Persada Saudara Pharma report to view the information.

Basic Information
Registered Capital:
Purchase the Pt Bhakti Persada Saudara Pharma report to view the information.
Financial Auditors:
Purchase the Pt Bhakti Persada Saudara Pharma report to view the information.
Incorporation Date:
September 18, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Commissioner
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Pt Bhakti Persada Saudara Pharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
9.35%
Total Operating Revenue
9.35%
Total Assets
12.66%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?